roxatidine acetate has been researched along with Chronic Disease in 1 studies
roxatidine acetate: structure given in first source
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Excerpt | Relevance | Reference |
|---|---|---|
| " Relationships between pharmacokinetic variables and each parameter related to hepatic functions were also investigated." | 1.31 | Pharmacokinetics of roxatidine acetate in patients with chronic liver disease. ( Takase, S; Tsutsumi, M; Ueshima, Y, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tsutsumi, M | 1 |
| Ueshima, Y | 1 |
| Takase, S | 1 |
1 other study available for roxatidine acetate and Chronic Disease
| Article | Year |
|---|---|
Pharmacokinetics of roxatidine acetate in patients with chronic liver disease.
Topics: Administration, Oral; Adult; Aged; Area Under Curve; Chronic Disease; Creatinine; Half-Life; Hepatit | 2001 |